
@article{middleton_peps2_2020,
	title = {Pembrolizumab in patients with non-small-cell lung cancer of performance status 2 ({PePS2}): a single arm, phase 2 trial},
	volume = {0},
	issn = {2213-2600, 2213-2619},
	shorttitle = {Pembrolizumab in patients with non-small-cell lung cancer of performance status 2 ({PePS2})},
	url = {https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30033-3/abstract},
	doi = {10.1016/S2213-2600(20)30033-3},
	language = {English},
	number = {0},
	urldate = {2020-03-21},
	journal = {The Lancet Respiratory Medicine},
	author = {Middleton, Gary and Brock, Kristian and Savage, Joshua and Mant, Rhys and Summers, Yvonne and Connibear, John and Shah, Riyaz and Ottensmeier, Christian and Shaw, Paul and Lee, Siow-Ming and Popat, Sanjay and Barrie, Colin and Barone, Gloria and Billingham, Lucinda},
	month = mar,
	year = {2020},
	note = {Publisher: Elsevier}
}